The World Health Organization has restarted its trial of COVID-19 drug hydroxychloroquine, the malaria drug favoured by president Donald Trump, after a temporary halt because of safety concerns.
privacy policy | terms of use | contact us | advertise | pharma jobs | pharma blogs | facebook | twitter
Copyright © 2024,